| Titre : |
The valuation of biotech companies The impact of R&D intensity on the market value of the biotech firms |
| Type de document : |
Mémoire |
| Auteurs : |
Oleg BEREZHNOY, Auteur |
| Année de publication : |
2022 |
| Importance : |
22 p. |
| Note générale : |
Pour accéder aux fichiers PDF, merci de vous identifier sur le catalogue avec cotre compte Office 365 via le bouton CONNEXION en haut de la page. |
| Langues : |
Anglais (eng) |
| Mots-clés : |
Management
EVALUATION ; EVALUATION D'UNE ENTREPRISE ; INNOVATION ; RECHERCHE
Delphes
RECHERCHE-DEVELOPPEMENT
|
| Résumé : |
In this study, we made an examination of different factors influencing the value of biotech companies. This analysis was conducted using the dependent variable EV/Revenue for
representation of the valuation of biotech companies and several independent explanatory variables. The results of the analysis show that the companies with high R&D intensity tend
to have a higher value. In other words, the market takes into consideration the R&D investments made by the biotech companies and anticipates a better performance from such
kinds of companies. We can also make a conclusion that the market treats CAPEX expenditures in line with R&D investments and, as a result, anticipates a better revenue
performance from biotech companies with higher CAPEX expenditures. It looks like the market doesn’t respond just to the fact of drug approval, as we didn’t find any links between
the biotech companies’ value and the product approval intensity. Finally, considering the significant level of biotech companies going on IPO with minimum revenues or without
revenues at all, we didn’t find any proof that the market gives more value to R&D investments made by less mature biotech companies. Despite a significant number of observations (1322), we should underline the fact that we base our analysis only on a one-year period due to high volatility in the healthcare industry provoked by the healthcare crises in recent years |
| Programme : |
MSc Corporate Finance |
| Permalink : |
https://cataloguelibrary.neoma-bs.fr/index.php?lvl=notice_display&id=568522 |
|  |
Ajouter le résultat dans votre panier Faire une suggestion Affiner la rechercheThe valuation of biotech companies The impact of R&D intensity on the market value of the biotech firms / 2022
Marque dans le produit [La] / DE BOECK (2013)
